Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. UnitedHealth Group kicked off second-quarter earnings for the health-care sector this week with results that topped Wall Street's expectations despite rising medical costs.
Those results eased investor concerns after UnitedHealth, the nation's largest health insurance company, flagged a surge in demand for non-urgent surgeries and outpatient services last month and spooked the market.
Meanwhile, the World Health Organization rang alarm bells about aspartame, the artificial sweetener used in Diet Coke, Pepsi Zero Sugar and other diet sodas.
The global health agency classified the sweetener as a possible carcinogen, but said it is safe for people to consume within the recommended daily limit, Spencer reports for us.
The U.S. Food and Drug Administration said it disagrees with the classification, noting that the studies used to reach that conclusion had "significant shortcomings."
The FDA grabbed more headlines this week after it approved the nation's first over-the-counter birth control pill, which will allow more women and girls to prevent unintended pregnancies without a prescription.
The pill's approval is a win for the Biden administration, which has tried to shore up reproductive rights as abortion restrictions rise in many states.
Feel free to send any tips, suggestions, story ideas and data to me at annikakim.constantino@gmail.com.
|
|
|
The results eased investor concerns after UnitedHealth Group flagged a surge in demand for non-urgent surgeries and outpatient services last month. - Annika Kim Constantino The FDA disagrees with the World Health Organization's classification of the soda sweetener aspartame as possibly carcinogenic to humans. - Spencer Kimball Perrigo's Opill could significantly expand access to contraception, especially for younger women who often face logistical barriers to get birth control. - Annika Kim Constantino The HHS program aims to maintain broad access to Covid shots and treatments after the federal government shifts those products to the commercial market. - Annika Kim Constantino The Biden administration unveiled a plan to eliminate the growing threat of fentanyl laced with xylazine, an illegal street drug cocktail that is fueling a wave of overdose deaths. - Annika Kim Constantino The U.S. Chamber of Commerce asked a judge to block the landmark ability of Medicare to negotiate drug prices. - Spencer Kimball The European Medicines Agency didn't specify which additional GLP-1 drugs are now being investigated, but it could potentially include Eli Lilly's Mounjaro. - Annika Kim Constantino |
|
| © 2023 CNBC LLC. All rights reserved. A property of NBCUniversal. 900 Sylvan Avenue, Englewood Cliffs, NJ 07632 Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes and Market Data and Analysis. Data also provided by THOMSON REUTERS |
|
|
|
If you believe this has been sent to you in error, please safely unsubscribe.
Tidak ada komentar:
Posting Komentar